...
首页> 外文期刊>Antioxidants and redox signalling >Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation.
【24h】

Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation.

机译:Ajoene是一种稳定的大蒜副产品,可通过LKB1依赖性AMPK激活抑制高脂饮食诱导的肝脂肪变性和氧化损伤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatic steatosis, a hepatic component of metabolic syndrome, is common and may progress to steatohepatitis and cirrhosis. The liver X receptor-alpha (LXRalpha)-sterol regulatory element binding protein-1c (SREBP-1c) pathway plays a key role in hepatic steatosis. This study investigated the potential of ajoene, a stable garlic by-product, to inhibit high fat diet (HFD)-induced hepatic steatosis and the underlying mechanism. Ajoene treatment attenuated fat accumulation and induction of lipogenic genes in the liver of HFD-fed mice. Blood biochemical analyses and histopathologic examinations showed that ajoene prevented liver injury with the inhibition of oxidative stress, as evidenced by thiobarbituric acid reactive substances formation and nitrotyrosinylation. Moreover, ajoene treatment inhibited LXRalpha agonist (T0901317)-mediated SREBP-1c activation, and transactivation of the lipogenic target genes in hepatocytes. Ajoene was found to activate AMP-activated protein kinase (AMPK) via LKB1, responsible for the inhibition of p70 ribosomal S6 kinase-1 (S6K1). The ability of ajoene to repress T0901317-induced SREBP-1c expression was antagonized by inhibition of AMPK or activation of S6K1, supporting the role of these kinases in the antisteatotic effect. Our results demonstrate that ajoene has an effect of activating AMPK through LKB1 and inhibit S6K1 activity, contributing to the prevention of SREBP-1c-mediated hepatic lipogenesis via the inhibition of LXRalpha activity.
机译:肝脂肪变性是代谢综合征的肝脏组成部分,很常见,可能会发展为脂肪性肝炎和肝硬化。肝X受体-α(LXRalpha)-固醇调节元件结合蛋白1c(SREBP-1c)途径在肝脂肪变性中起关键作用。这项研究调查了稳定的大蒜副产品阿jo烯抑制高脂饮食(HFD)引起的肝脂肪变性及其潜在机制的潜力。阿霍烯疗法可减轻HFD喂养小鼠肝脏中的脂肪积累和脂肪生成基因的诱导。血液生化分析和组织病理学检查显示,阿霍烯可以通过抑制氧化应激来预防肝损伤,如硫代巴比妥酸反应性物质的形成和硝基酪氨酰化所证明的。此外,阿霍烯处理可抑制LXRalpha激动剂(T0901317)介导的SREBP-1c活化和肝细胞中脂肪生成靶基因的反式激活。发现Ajoene通过LKB1激活了AMP激活的蛋白激酶(AMPK),从而抑制了p70核糖体S6激酶-1(S6K1)。通过抑制AMPK或激活S6K1来抑制ajoene抑制T0901317诱导的SREBP-1c表达的能力,从而支持了这些激酶在抗硬脂化作用中的作用。我们的结果表明,阿霍烯具有通过LKB1激活AMPK并抑制S6K1活性的作用,有助于通过抑制LXRalpha活性来预防SREBP-1c介导的肝脂肪形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号